Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Abcellera Biologics Inc (ABCL)

  • Event
  • July 06, 2022, 20:57 UTC
  • 20
  • 1 comments

(50% Neutral) ABCELLERA BIOLOGICS INC. (ABCL) Announces Executive Departure

Comment Full text

CytomX Therapeutics Inc (CTMX)

  • Event
  • July 06, 2022, 20:10 UTC
  • 20
  • 1 comments

(85% Positive) CYTOMX THERAPEUTICS, INC. (CTMX) Announces Clinical Development Update

Comment Full text

Genmab (GMAB)

  • Event
  • July 06, 2022, 13:06 UTC
  • 19
  • 1 comments

(99% Neutral) Genmab (GMAB) Files Form 6-K

Comment Full text

Applied Molecular Transport Inc (merged with Cyclo Therapeutics (CYTH)) (AMTI)

  • Event
  • July 06, 2022, 12:01 UTC
  • 20
  • 1 comments

(70% Positive) APPLIED MOLECULAR TRANSPORT INC. (AMTI) Announces Clinical Development Update

Comment Full text

Passage Bio Inc (PASG)

  • Event
  • July 06, 2022, 11:00 UTC
  • 20
  • 1 comments

(99% Neutral) PASSAGE BIO, INC. (PASG) Announces New Board Appointment

Comment Full text

HUTCHMED DRC (HCM)

  • Event
  • July 06, 2022, 10:15 UTC
  • 19
  • 1 comments

(75% Positive) HUTCHMED DRC (HCM) Announces Clinical Development Update (Form 6-K)

Comment Full text

KAMADA (KMDA)

  • Event
  • July 06, 2022, 10:01 UTC
  • 19
  • 1 comments

(10% Negative) KAMADA (KMDA) Announces Clinical Development Update (Form 6-K)

Comment Full text

SAB Biotherapeutics (SABS)

  • Event
  • July 05, 2022, 20:31 UTC
  • 19
  • 1 comments

(10% Negative) SAB BIOTHERAPEUTICS, INC. (SABS) Files Form 8-K

Comment Full text

Mereo BioPharma (MREO)

  • Event
  • July 05, 2022, 20:15 UTC
  • 19
  • 1 comments

(98% Neutral) Mereo BioPharma (MREO) Announces Clinical Development Update (Form 6-K)

Comment Full text

CureVac (CVAC)

  • Event
  • July 05, 2022, 20:15 UTC
  • 19
  • 1 comments

(99% Neutral) CureVac (CVAC) Announces Clinical Development Update (Form 6-K)

Comment Full text
  • Previous
  • 563
  • 564
  • 565
  • 566
  • 567
  • Next

Search

News categories

  • Technical Exchange News(12514)
  • Event(6229)
  • SEC News(284157)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(162140)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin